Takeda Pharmaceutical Company Limited (TAK)
$18.52-0.86%Close
SELLBULL · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $58.9B
- Beta
- 0.09
- Div yield
- 3.38%
- P/E (TTM)
- 52.21
- Short % float
- 0.09%
- Days to cover
- 1.2
- SI change
- -30.6%
- 1W
- +2.32%
- 1M
- +1.31%
- vs SPY 1W
- +2.46%
- vs SPY 1M
- -1.19%
Industry peers
FMP comparable companies · ranked by market cap
- LLYBUYEli Lilly and Company$1.1TRECOVERYQ 21$1188.72-1.36%
- MRKSELLMerck & Co., Inc.$352.7BBEARQ 11$142.79-2.39%
- AZNSELLAstraZeneca PLC$248.3BRECOVERYQ 20$160.12-1.59%
- AMGNBUYAmgen Inc.$222.9BRECOVERYQ 22$413.08-1.13%
- PFESELLPfizer Inc.$159.6BBULLQ 13$28.00-0.11%
- BMYSELLBristol-Myers Squibb Company$121.9BBEARQ 10$59.70-1.58%
- SNYSELLSanofi$96.5BBEARQ 11$40.20-1.56%
- CHGCFChugai Pharmaceutical Co., Ltd.$63.0B$38.26
- ALPMYAstellas Pharma Inc.$25.5B$14.20
- GRFSSELLGrifols, S.A.$6.3BRECOVERYQ 5$7.50-2.71%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TAK?
- LOPJLB’s latest quantitative signal on Takeda Pharmaceutical Company Limited (TAK) is SELL in a BULL regime. Signals are updated daily.
- What market regime is TAK in?
- Takeda Pharmaceutical Company Limited (TAK) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Takeda Pharmaceutical Company Limited (TAK) do?
- Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and numerous other Asian and worldwide mar…